PTAB Grills Mylan And Merck In Diabetes Drug IP Battle
Attorneys for Mylan and Merck & Co. Inc. faced tough questions from a Patent Trial and Appeal Board judge Thursday in Mylan's bid to knock out a patent on Merck's blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article